scPharmaceuticals (SCPH) PT Raised to $18 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts SCPH Hot Sheet
Price: $5.67 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao raised the price target on scPharmaceuticals (NASDAQ: SCPH) to $18.00 (from $15.00) while maintaining a Buy rating.
You May Also Be Interested In
- Barclays Upgrades Crown Castle (CCI) to Overweight
- Barclays Upgrades American Tower (AMT) to Overweight
- CIBC Upgrades National Bank of Canada (NA:CN) (NTIOF) to Outperformer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
